Disease severity in newly diagnosed glaucoma patients with visual field loss: Trends from more than a decade of data

Ophthalmic and Physiological Optics

Volumn 35, Issue 2, 2015, Pages 225-230

  Boodhna, Trishal ^a   Crabb, David P ^a  

^a CITY UNIVERSITY   (United Kingdom)

Author keywords

Glaucoma detection; Glaucoma referral; Trend analysis; Visual field

Indexed keywords

ADULT; AGED; DISABILITY; DISEASE COURSE; FEMALE; GLAUCOMA; HUMAN; MALE; MIDDLE AGED; OPHTHALMOLOGY; PATHOPHYSIOLOGY; PERIMETRY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED KINGDOM; VERY ELDERLY; VISION DISORDERS; VISUAL FIELD;

ADULT; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; DISEASE PROGRESSION; ENGLAND; FEMALE; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; OPHTHALMOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; VISION DISORDERS; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84924479345     PISSN: 02755408     EISSN: 14751313     Source Type: Journal    
DOI: 10.1111/opo.12187     Document Type: Article

References (39)

1. Quigley HA & Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267.
2. Kotecha A, Turner S, Vasilakis C et al. Improving care and increasing efficiency-challenges in the care of chronic eye diseases. Eye (Lond) 2014; 28: 779-783.
3. NICE. Glaucoma: Diagnosis and Management of Chronic Open Angle Glaucoma and Ocular Hypertension. National Institute of Health and Clinical Excellence: http://www.nice.org.uk/nicemedia/pdf/CG85FullGuideline.pdf (last accessed 4 June 2014) 2009.
4. Fraser S, Bunce C, Wormald R & Brunner E. Deprivation and late presentation of glaucoma: case-control study. BMJ 2001; 322: 639-643.
5. Prior M, Francis JJ, Azuara-Blanco A, Anand N & Burr JM. Why do people present late with advanced glaucoma? A qualitative interview study. Br J Ophthalmol 2013; 97: 1574-1578.
6. Burr JM, Mowatt G, Hernandez R et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess 2007; 11: iii-iv, ix-x, 1-190.
7. Konstantakopoulou E, Harper RA, Edgar DF & Lawrenson JG. A qualitative study of stakeholder views regarding participation in locally commissioned enhanced optometric services. BMJ Open 2014; 4: e004781.
8. Trikha S, Macgregor C, Jeffery M & Kirwan J. The Portsmouth-based glaucoma refinement scheme: a role for virtual clinics in the future. Eye (Lond) 2012; 26: 1288-1294.
9. Bourne RR, French KA, Chang L, Borman AD, Hingorani M & Newsom WD. Can a community optometrist-based referral refinement scheme reduce false-positive glaucoma hospital referrals without compromising quality of care? The community and hospital allied network glaucoma evaluation scheme (CHANGES). Eye (Lond) 2009; 24: 881-887.
10. Parkins DJ & Edgar DF. Comparison of the effectiveness of two enhanced glaucoma referral schemes. Ophthalmic Physiol Opt 2011; 31: 343-352.
11. Sharma A, Jofre-Bonet M, Panca M, Lawrenson JG & Murdoch I. An economic comparison of hospital-based and community-based glaucoma clinics. Eye (Lond) 2012; 26: 967-971.
12. Keenan J, Shahid H, Bourne RR, White AJ & Martin KR. Cambridge community Optometry Glaucoma Scheme (COGS). Clin Experiment Ophthalmol [serial on the Internet]. 2014; doi: 10.1111/ceo.12398, accessed 10/08/14.
13. Ratnarajan G, Newsom W, French K et al. The impact of glaucoma referral refinement criteria on referral to, and first-visit discharge rates from, the hospital eye service: the Health Innovation & Education Cluster (HIEC) Glaucoma Pathways project. Ophthalmic Physiol Opt 2013; 33: 183-189.
14. Rapsomaniki E, Timmis A, George J et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 2014; 383: 1899-1991.
15. Sparrow JM, Taylor H, Qureshi K, Smith R & Johnston RL. The cataract national data set electronic multi-centre audit of 55 567 operations: case-mix adjusted surgeon's outcomes for posterior capsule rupture. Eye (Lond) 2011; 25: 1010-1015.
16. Tufail A, Xing W, Johnston R et al. The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections. Ophthalmology 2014; 121: 1092-1101.
17. Saunders LJ, Russell RA, Kirwan JF, McNaught AI & Crabb DP. Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime. Invest Ophthalmol Vis Sci 2014; 55: 102-109.
18. Saunders LJ, Russell RA & Crabb DP. Practical landmarks for visual field disability in glaucoma. Br J Ophthalmol 2012; 96: 1185-1189.
19. Hodapp E, Parrish RI & Anderson DR. Clinical Decisions in Glaucoma.The CV Mosby: St Louis, MO, 1993; pp. 84-125.
20. Mills RP, Budenz DL, Lee PP et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 2006; 141: 24-30.
21. O'Colmain U, Anijeet D, Vosoughi M, Sinclair A & Sanders R. Glaucoma blind registration in Fife (2000-2009) - a retrospective cohort study. Ophthalmic Physiol Opt 2011; 31: 360-366.
22. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L & Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121: 48-56.
23. Dabasia PL, Edgar DF, Garway-Heath DF & Lawrenson JG. A survey of current and anticipated use of standard and specialist equipment by UK optometrists. Ophthalmic Physiol Opt 2014; 34: 592-613.
24. Myint J, Edgar DF, Kotecha A, Murdoch IE & Lawrenson JG. Barriers perceived by UK-based community optometrists to the detection of primary open angle glaucoma. Ophthalmic Physiol Opt 2010; 30: 847-853.
25. Myint J, Edgar DF, Kotecha A, Crabb DP & Lawrenson JG. Development of a competency framework for optometrists with a specialist interest in glaucoma. Eye (Lond) 2010; 24: 1509-1514.
26. Silva SR, Riaz Y, Purbrick RM & Salmon JF. There is a trend for the diagnosis of glaucoma to be made at an earlier stage in 2010 compared to 2008 in Oxford, United Kingdom. Ophthalmic Physiol Opt 2013; 33: 179-182.
27. Khan S, Clarke J & Kotecha A. Comparison of optometrist glaucoma referrals against published guidelines. Ophthalmic Physiol Opt 2012; 32: 472-477.
28. Shah S & Murdoch IE. NICE - impact on glaucoma case detection. Ophthalmic Physiol Opt 2011; 31: 339-342.
29. Vernon SA, Hillman JG, MacNab HK et al. Community optometrist referral of those aged 65 and over for raised IOP post-NICE: AOP guidance versus joint college guidance-an epidemiological model using BEAP. Br J Ophthalmol 2011; 95(11): 1534-1536.
30. Fraser S, Bunce C & Wormald R. Risk factors for late presentation in chronic glaucoma. Invest Ophthalmol Vis Sci 1999; 40: 2251-2257.
31. Ng WS, Agarwal PK, Sidiki S, McKay L, Townend J & Azuara-Blanco A. The effect of socio-economic deprivation on severity of glaucoma at presentation. Br J Ophthalmol 2010; 94: 85-87.
32. Kotecha A, Fernandes S, Bunce C & Franks WA. Avoidable sight loss from glaucoma: is it unavoidable? Br J Ophthalmol 2012; 96: 816-820.
33. Glen FC, Baker H & Crabb DP. A qualitative investigation into patients' views on visual field testing for glaucoma monitoring. BMJ Open 2014; 4: e003996.
34. Lockwood AJ, Kirwan JF & Ashleigh Z. Optometrists referrals for glaucoma assessment: a prospective survey of clinical data and outcomes. Eye (Lond) 2010; 24: 1515-1519.
35. Henson DB & Thampy R. Preventing blindness from glaucoma. BMJ 2005; 331: 120-121.
36. Montolio FGJ, Wesselink C, Gordijn M & Jansonius NM. Factors that influence standard automated perimetry test results in glaucoma: test reliability, technician experience, time of day, and season. Invest Ophthalmol Vis Sci 2012; 53: 7010-7017.
37. Bengtsson B. Reliability of computerized perimetric threshold tests as assessed by reliability indices and threshold reproducibility in patients with suspect and manifest glaucoma. Acta Ophthalmol Scand 2000; 78: 519-522.
38. Jackson TL, Donachie PH, Sparrow JM & Johnston RL. United Kingdom National Ophthalmology Database study of vitreoretinal surgery: report 2, macular hole. Ophthalmology 2013; 120: 629-634.
39. Keenan TD, Johnston RL, Donachie PH, Sparrow JM, Stratton IM & Scanlon P. United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services. Eye (Lond) 2013; 27: 1397-1404.